Cullinan Oncology Llc Stock Price History
| CGEM Stock | USD 8.52 0.20 2.29% |
Below is the normalized historical share price chart for Cullinan Oncology LLC extending back to January 08, 2021. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cullinan Oncology stands at 8.52, as last reported on the 21st of March, with the highest price reaching 8.76 and the lowest price hitting 8.44 during the day.
If you're considering investing in Cullinan Stock, it is important to understand the factors that can impact its price. Cullinan Oncology LLC secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15 % return per unit of risk over the last 3 months. Cullinan Oncology LLC exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cullinan Oncology's Standard Deviation of 3.31, mean deviation of 2.6, and Risk Adjusted Performance of (0.11) to double-check the risk estimate we provide.
At this time, Cullinan Oncology's Common Stock is very stable compared to the past year. As of the 21st of March 2025, Total Stockholder Equity is likely to grow to about 619.8 M, while Liabilities And Stockholders Equity is likely to drop about 385.3 M. . At this time, Cullinan Oncology's Price Book Value Ratio is very stable compared to the past year. As of the 21st of March 2025, Price To Book Ratio is likely to grow to 0.88, while Price Earnings Ratio is likely to drop (2.61). Cullinan Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of January 2021 | 200 Day MA 14.7527 | 50 Day MA 9.631 | Beta (0.11) |
Cullinan |
Sharpe Ratio = -0.155
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CGEM |
Estimated Market Risk
| 3.22 actual daily | 28 72% of assets are more volatile |
Expected Return
| -0.5 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cullinan Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cullinan Oncology by adding Cullinan Oncology to a well-diversified portfolio.
Price Book 0.8643 | Enterprise Value Ebitda (1.46) | Price Sales 26.8794 | Shares Float 39 M | Wall Street Target Price 32.4444 |
Cullinan Oncology Stock Price History Chart
There are several ways to analyze Cullinan Stock price data. The simplest method is using a basic Cullinan candlestick price chart, which shows Cullinan Oncology price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 26, 2024 | 12.9 |
| Lowest Price | March 3, 2025 | 8.0 |
Cullinan Oncology March 21, 2025 Stock Price Synopsis
Various analyses of Cullinan Oncology's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cullinan Stock. It can be used to describe the percentage change in the price of Cullinan Oncology from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cullinan Stock.| Cullinan Oncology Price Action Indicator | (0.18) | |
| Cullinan Oncology Accumulation Distribution | 29,039 | |
| Cullinan Oncology Price Daily Balance Of Power | (0.63) | |
| Cullinan Oncology Price Rate Of Daily Change | 0.98 |
Cullinan Oncology March 21, 2025 Stock Price Analysis
Cullinan Stock Price History Data
The price series of Cullinan Oncology for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 4.9 with a coefficient of variation of 13.0. The prices are distributed with arithmetic mean of 10.19. The median price for the last 90 days is 10.21. The company had 2:1 stock split on 31st of August 2009.| Open | High | Low | Close | Volume | ||
| 03/21/2025 | 8.64 | 8.76 | 8.44 | 8.52 | 794,952 | |
| 03/20/2025 | 8.55 | 8.76 | 8.49 | 8.72 | 319,447 | |
| 03/19/2025 | 8.92 | 8.92 | 8.41 | 8.65 | 328,460 | |
| 03/18/2025 | 8.86 | 9.07 | 8.37 | 8.93 | 384,727 | |
| 03/17/2025 | 8.77 | 9.16 | 8.74 | 9.03 | 400,157 | |
| 03/14/2025 | 9.00 | 9.01 | 8.57 | 8.79 | 341,773 | |
| 03/13/2025 | 9.01 | 9.38 | 8.65 | 8.92 | 392,534 | |
| 03/12/2025 | 8.73 | 9.19 | 8.63 | 9.08 | 404,382 | |
| 03/11/2025 | 8.10 | 8.72 | 7.95 | 8.67 | 717,157 | |
| 03/10/2025 | 8.55 | 8.65 | 8.09 | 8.15 | 606,346 | |
| 03/07/2025 | 8.70 | 9.09 | 8.48 | 8.71 | 437,813 | |
| 03/06/2025 | 8.39 | 8.62 | 8.24 | 8.51 | 256,827 | |
| 03/05/2025 | 8.26 | 8.53 | 8.06 | 8.43 | 330,249 | |
| 03/04/2025 | 7.90 | 8.32 | 7.90 | 8.13 | 564,429 | |
| 03/03/2025 | 8.60 | 8.64 | 7.95 | 8.00 | 476,667 | |
| 02/28/2025 | 8.65 | 8.68 | 8.29 | 8.49 | 718,328 | |
| 02/27/2025 | 8.64 | 8.87 | 8.43 | 8.61 | 385,149 | |
| 02/26/2025 | 8.55 | 8.71 | 8.39 | 8.45 | 309,545 | |
| 02/25/2025 | 8.53 | 8.83 | 8.35 | 8.56 | 606,821 | |
| 02/24/2025 | 9.04 | 9.07 | 8.61 | 8.72 | 342,575 | |
| 02/21/2025 | 9.19 | 9.28 | 8.92 | 9.03 | 323,682 | |
| 02/20/2025 | 9.35 | 9.51 | 9.00 | 9.15 | 370,903 | |
| 02/19/2025 | 9.23 | 9.47 | 9.09 | 9.43 | 524,923 | |
| 02/18/2025 | 9.53 | 9.82 | 9.06 | 9.26 | 340,459 | |
| 02/14/2025 | 9.58 | 9.93 | 9.47 | 9.53 | 280,816 | |
| 02/13/2025 | 9.96 | 9.96 | 9.48 | 9.59 | 284,611 | |
| 02/12/2025 | 9.60 | 9.95 | 9.50 | 9.89 | 248,725 | |
| 02/11/2025 | 10.00 | 10.27 | 9.77 | 9.81 | 366,381 | |
| 02/10/2025 | 10.26 | 10.32 | 10.00 | 10.10 | 310,949 | |
| 02/07/2025 | 10.40 | 10.58 | 10.05 | 10.21 | 374,568 | |
| 02/06/2025 | 10.31 | 10.70 | 10.05 | 10.35 | 1,376,507 | |
| 02/05/2025 | 10.20 | 10.62 | 10.08 | 10.30 | 338,556 | |
| 02/04/2025 | 10.01 | 10.51 | 9.99 | 10.20 | 345,253 | |
| 02/03/2025 | 10.25 | 10.54 | 10.00 | 10.06 | 307,947 | |
| 01/31/2025 | 11.04 | 11.28 | 10.37 | 10.56 | 412,394 | |
| 01/30/2025 | 11.51 | 11.92 | 10.73 | 10.98 | 593,179 | |
| 01/29/2025 | 10.82 | 11.89 | 10.50 | 11.25 | 665,179 | |
| 01/28/2025 | 10.36 | 10.57 | 10.11 | 10.45 | 234,664 | |
| 01/27/2025 | 10.48 | 10.88 | 10.18 | 10.30 | 335,174 | |
| 01/24/2025 | 10.53 | 10.75 | 10.35 | 10.55 | 617,772 | |
| 01/23/2025 | 10.43 | 10.60 | 10.24 | 10.56 | 318,085 | |
| 01/22/2025 | 10.40 | 10.59 | 10.14 | 10.51 | 423,383 | |
| 01/21/2025 | 10.39 | 10.52 | 10.26 | 10.42 | 345,843 | |
| 01/17/2025 | 10.28 | 10.52 | 10.17 | 10.26 | 273,964 | |
| 01/16/2025 | 10.12 | 10.45 | 10.01 | 10.14 | 474,067 | |
| 01/15/2025 | 10.22 | 10.37 | 9.83 | 10.18 | 702,776 | |
| 01/14/2025 | 11.19 | 11.31 | 9.50 | 10.01 | 873,031 | |
| 01/13/2025 | 11.16 | 11.23 | 10.69 | 11.04 | 705,110 | |
| 01/10/2025 | 10.94 | 11.26 | 10.50 | 11.19 | 1,244,678 | |
| 01/08/2025 | 11.58 | 11.81 | 11.07 | 11.13 | 349,214 | |
| 01/07/2025 | 11.76 | 12.16 | 11.36 | 11.56 | 385,276 | |
| 01/06/2025 | 12.62 | 12.78 | 11.75 | 11.78 | 386,906 | |
| 01/03/2025 | 12.45 | 12.99 | 12.45 | 12.68 | 294,000 | |
| 01/02/2025 | 12.74 | 12.95 | 12.19 | 12.39 | 422,788 | |
| 12/31/2024 | 12.37 | 12.85 | 11.99 | 12.18 | 361,761 | |
| 12/30/2024 | 11.75 | 12.28 | 11.75 | 12.20 | 552,687 | |
| 12/27/2024 | 12.88 | 12.88 | 11.81 | 12.02 | 1,400,300 | |
| 12/26/2024 | 12.07 | 12.95 | 11.88 | 12.90 | 743,245 | |
| 12/24/2024 | 11.87 | 12.38 | 11.68 | 12.27 | 157,806 | |
| 12/23/2024 | 11.61 | 11.97 | 11.34 | 11.87 | 714,785 | |
| 12/20/2024 | 10.87 | 11.86 | 10.78 | 11.60 | 875,853 |
About Cullinan Oncology Stock history
Cullinan Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cullinan is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cullinan Oncology LLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cullinan Oncology stock prices may prove useful in developing a viable investing in Cullinan Oncology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 58.5 M | 45.5 M | |
| Net Income Applicable To Common Shares | 127.9 M | 134.3 M |
Cullinan Oncology Quarterly Net Working Capital |
|
Cullinan Oncology Stock Technical Analysis
Cullinan Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Cullinan Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cullinan Oncology's price direction in advance. Along with the technical and fundamental analysis of Cullinan Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cullinan to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.19) | |||
| Treynor Ratio | (0.74) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cullinan Oncology LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cullinan Oncology. If investors know Cullinan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cullinan Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cullinan Oncology LLC is measured differently than its book value, which is the value of Cullinan that is recorded on the company's balance sheet. Investors also form their own opinion of Cullinan Oncology's value that differs from its market value or its book value, called intrinsic value, which is Cullinan Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cullinan Oncology's market value can be influenced by many factors that don't directly affect Cullinan Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cullinan Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cullinan Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cullinan Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.